Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Zhejiang CONBA Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million ≈ $19.52 Million USD) by net assets (CN¥7.16 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)

Cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang CONBA Pharmaceutical Co Ltd (600572) stock price for real-time trading data and today's change.

Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang CONBA Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Zhejiang CONBA Pharmaceutical Co Ltd (600572) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
MicroPort Endovascular MedTech Ltd SHG:688016	0.011x
Antin IP SA PA:ANTIN	0.108x
Partner TA:PTNR	0.114x
Global Net Lease, Inc. NYSE:GNL	0.044x
CleanSpark Inc NASDAQ:CLSK	-0.148x
GigaCloud Technology Inc Class A Ordinary Shares NASDAQ:GCT	0.132x
ManpowerGroup Inc NYSE:MAN	-0.061x
PharmaBlock Sciences Nanjing Inc Class A SHE:300725	0.018x

Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. Review Zhejiang CONBA Pharmaceutical Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥7.15 Billion ≈ $1.05 Billion	CN¥942.61 Million ≈ $137.93 Million	0.132x	-10.02%
2024-12-31	CN¥6.91 Billion ≈ $1.01 Billion	CN¥1.01 Billion ≈ $148.16 Million	0.146x	+19.80%
2023-12-31	CN¥7.35 Billion ≈ $1.08 Billion	CN¥898.64 Million ≈ $131.50 Million	0.122x	-22.50%
2022-12-31	CN¥7.32 Billion ≈ $1.07 Billion	CN¥1.16 Billion ≈ $169.08 Million	0.158x	+31.05%
2021-12-31	CN¥7.39 Billion ≈ $1.08 Billion	CN¥889.94 Million ≈ $130.23 Million	0.120x	-48.47%
2020-12-31	CN¥5.35 Billion ≈ $782.79 Million	CN¥1.25 Billion ≈ $182.87 Million	0.234x	+24.76%
2019-12-31	CN¥4.94 Billion ≈ $723.27 Million	CN¥925.50 Million ≈ $135.43 Million	0.187x	+98.73%
2018-12-31	CN¥5.79 Billion ≈ $847.64 Million	CN¥545.78 Million ≈ $79.86 Million	0.094x	-22.70%
2017-12-31	CN¥5.84 Billion ≈ $855.11 Million	CN¥712.27 Million ≈ $104.23 Million	0.122x	-43.59%
2016-12-31	CN¥4.49 Billion ≈ $656.77 Million	CN¥969.71 Million ≈ $141.90 Million	0.216x	+18.66%
2015-12-31	CN¥4.57 Billion ≈ $668.05 Million	CN¥831.26 Million ≈ $121.64 Million	0.182x	-0.61%
2014-12-31	CN¥3.37 Billion ≈ $493.18 Million	CN¥617.43 Million ≈ $90.35 Million	0.183x	+101.72%
2013-12-31	CN¥2.59 Billion ≈ $379.22 Million	CN¥235.36 Million ≈ $34.44 Million	0.091x	-9.81%
2012-12-31	CN¥2.44 Billion ≈ $357.14 Million	CN¥245.76 Million ≈ $35.96 Million	0.101x	-13.82%
2011-12-31	CN¥1.61 Billion ≈ $235.90 Million	CN¥188.36 Million ≈ $27.56 Million	0.117x	+59.22%
2010-12-31	CN¥1.72 Billion ≈ $251.12 Million	CN¥125.93 Million ≈ $18.43 Million	0.073x	-45.11%
2009-12-31	CN¥1.15 Billion ≈ $167.90 Million	CN¥153.39 Million ≈ $22.45 Million	0.134x	+24.75%
2008-12-31	CN¥919.66 Million ≈ $134.58 Million	CN¥98.56 Million ≈ $14.42 Million	0.107x	+14.52%
2007-12-31	CN¥854.74 Million ≈ $125.08 Million	CN¥79.98 Million ≈ $11.70 Million	0.094x	-17.51%
2006-12-31	CN¥627.66 Million ≈ $91.85 Million	CN¥71.20 Million ≈ $10.42 Million	0.113x	-42.62%
2005-12-31	CN¥595.08 Million ≈ $87.08 Million	CN¥117.65 Million ≈ $17.22 Million	0.198x	+70.62%
2004-12-31	CN¥565.05 Million ≈ $82.68 Million	CN¥65.47 Million ≈ $9.58 Million	0.116x	-58.37%
2003-12-31	CN¥239.44 Million ≈ $35.04 Million	CN¥66.64 Million ≈ $9.75 Million	0.278x	--

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

CN¥10.81 Billion CNY

Market Cap Rank

#6774 Global

#1362 in China

Share Price

CN¥4.26

Change (1 day)

-2.07%

52-Week Range

CN¥3.88 - CN¥4.94

All Time High

CN¥10.42